In this powerful DiepCJourney® podcast episode, Dr. Anne Peled and Dr. Ziv Peled, renowned experts in breast reconstruction and pain management join forces to explore the groundbreaking potential of Journavx, a new non-opioid oral pain medication designed to address acute post-surgical pain. With a shared commitment to improving patient outcomes and reducing reliance on opioids, this is the first FDA approved non-opioid oral pain medication for acute pain approved by the FDA in twenty years. They unpack the science behind Journavx, its clinical applications, and what it means for the future of recovery after breast reconstruction.

Listeners will gain:

• 🎙️ A deep dive into how Journavx works and why it matters
• 💡 Insights from Dr. Ziv Peled’s experience as a peripheral nerve surgeon
• 💬 Dr. Anne Peled’s perspective on patient-centered care and her personal experience after her recent implant-based breast reconstruction surgery
• 🔍 Discussion on shifting paradigms in pain management and survivorship

Whether you're a patient, provider, or advocate, this episode offers hope, innovation, and practical knowledge for navigating post-operative healing with greater confidence and comfort.

Be sure to check out the video episode on the DiepCFoundation YouTube channel here:

https://www.youtube.com/watch?v=GXOO8yotZyc&t=1365s

Connect with Dr. Anne Peled on the following platforms:

Instagram: https://www.instagram.com/drannepeled/

LinkedIn: https://www.linkedin.com/in/anne-peled-31626284/

Facebook: https://www.facebook.com/drannepeled

Connect with Dr. Ziv Peled on the following platforms:

Instagram: https://www.instagram.com/peledsurgery/

LinkedIn: https://www.linkedin.com/in/ziv-m-peled-md/

Facebook: https://www.facebook.com/PeledSurgery